Scott A. Shell
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 4
- MicroRNA in disease regulation 3
- Molecular Biology top 10%
- RNA Research and Splicing 5
- Pluripotent Stem Cells Research 2
- RNA modifications and cancer 2
-
- Chemotherapy-induced cardiotoxicity and mitigation 2
- Reproductive Medicine top 10%
-
- Lung Cancer Treatments and Mutations 4
-
- Chronic Myeloid Leukemia Treatments 2
- Co-authors
- Robert SchickelSun-Mi ParkMarcus E. PeterChristine FeigA. Reza RadjabiErnst LengyelSarah BacusPatricia B. Trusk
- Journals
- Toxicology and Applied Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)Cell Cycle (2 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Scott A. Shell
20 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Cancer Research 473
- Molecular Biology 748
- Oncology 167
- Cardiology and Cardiovascular Medicine 126
- Reproductive Medicine 46
Countries citing papers authored by Scott A. Shell
This map shows the geographic impact of Scott A. Shell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Shell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Shell more than expected).
Fields of papers citing papers by Scott A. Shell
This network shows the impact of papers produced by Scott A. Shell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Shell. The network helps show where Scott A. Shell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott A. Shell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 18 | |
| 3 | 2022 | 3 | |
| 4 | 2021 | 3 | |
| 5 | 2015 | 62 | |
| 6 | 2014 | 61 | |
| 7 | 2014 | 1 | |
| 8 | 2013 | 5 | |
| 9 | 2013 | 136 | |
| 10 | 2012 | 3 | |
| 11 | 2008 | 40 | |
| 12 | 2008 | 1 | |
| 13 | 2008 | 1 | |
| 14 | 2007 | 17 | |
| 15 | 2007 | 193 | |
| 16 | 2007 | 377 | |
| 17 | 2006 | 1 | |
| 18 | 2005 | 83 | |
| 19 | REGULATION OF THE 64-kDA SUBUNIT OF CLEAVAGE STIMULATORY FACTOR ACTIVITY IN MACROPHAGE AND B LYMPHOCYTE mRNA 3'-END PROCESSING | 2005 | 1 |
| 20 | 2002 | 21 |
About Scott A. Shell
Scott A. Shell is a scholar working on Cancer Research, Oncology, Molecular Biology, Hematology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 1.0k indexed citations. Recurring topics across this work include RNA Research and Splicing (5 papers), Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (4 papers), MicroRNA in disease regulation (3 papers), Pluripotent Stem Cells Research (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), RNA modifications and cancer (2 papers) and Chemotherapy-induced cardiotoxicity and mitigation (2 papers). The work is most often cited by research in Cancer Research (473 citations), Molecular Biology (748 citations), Oncology (167 citations), Cardiology and Cardiovascular Medicine (126 citations) and Reproductive Medicine (46 citations). Scott A. Shell has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Robert Schickel, Sun-Mi Park, Marcus E. Peter, Christine Feig, A. Reza Radjabi, Ernst Lengyel, Sarah Bacus, Patricia B. Trusk, Emily O. Kistner and David A. Jewell. Their work appears in journals such as Toxicology and Applied Pharmacology, Journal of Clinical Oncology, Cell Cycle, Cancer Research and Molecular Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.